Metraipolis › archive › dc_325e8a2f02be

Niraparib promotes ferroptosis by inhibiting TM4SF1 expression through ALKBH1-mediated 6mA modification in BRCA wild-type ovarian cancer — Europe PMC PMID:42305440

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42305440
DOI
10.3389/fphar.2026.1706364
License (as archived)
solo-consultazione
Archived
2026-10-31T21:13:45.425Z
SHA-256 of the archived text
e1ece495f3a3891adb8df273419ac0d78faef51485ff3caed6235ee4e3873ad7
Stable URL of this page
https://metraipolis.com/documento/dc_325e8a2f02be

How to cite

Niraparib promotes ferroptosis by inhibiting TM4SF1 expression through ALKBH1-mediated 6mA modification in BRCA wild-type ovarian cancer — Europe PMC PMID:42305440 — Europe PMC (en), https://europepmc.org/article/MED/42305440 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_325e8a2f02be (Metraipolis archive dc_325e8a2f02be, sha256 e1ece495f3a3891adb8df273419ac0d78faef51485ff3caed6235ee4e3873ad7)
BibTeX
@misc{dc325e8a2f02be,
  title = {Niraparib promotes ferroptosis by inhibiting TM4SF1 expression through ALKBH1-mediated 6mA modification in BRCA wild-type ovarian cancer — Europe PMC PMID:42305440},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42305440},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_325e8a2f02be; sha256 e1ece495f3a3891adb8df273419ac0d78faef51485ff3caed6235ee4e3873ad7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42305440. Agents can read the archived copy with the MCP tool read_document.